OnCo
frontsFront

Devices & Physical Therapies

Devices and physical therapies treat cancer with electric fields, heat, or sound rather than chemicals.

Tumour treating fields (Optune, now approved in pancreatic cancer), hyperthermia, HIFU, histotripsy, photodynamic and photoimmunotherapy, electroporation, and intraoperative devices.

Devices & Physical Therapies: how this front works · animated schematic, not to scale

Technologies

14top
Established
Electrochemotherapy

Brief electric pulses applied to a tumour open pores in cell membranes so that a tiny dose of bleomycin or cisplatin floods in; used for skin metastases and, increasingly, for deep tumours.

Established
Focused ultrasound & histotripsy

Destroying tumours from outside the body with tightly focused sound waves, using either heat or microscopic bubbles.

Phase 2
Focused-ultrasound blood-brain barrier opening

Sound waves plus microbubbles briefly open the brain's protective barrier so chemotherapy or antibodies can get to the tumour.

Established
Hyperthermia

Hyperthermia heats tumours to 40-43 °C to make radiation and chemotherapy work better.

Standard of care
Infusion pumps, ports, and ambulatory chemotherapy devices

Infusion devices are the implanted ports, smart pumps, and take-home pumps that deliver chemotherapy safely, including 46-hour infusions patients carry home.

Phase 2
Intratumoural gene electrotransfer (IL-12 plasmid)

Injecting the gene for a powerful immune cytokine into a tumour and using an electric pulse to push it into the cells, so the cytokine is made locally rather than flooding the body.

Standard of care
Intravesical therapy (BCG, chemotherapy, devices, gene and viral therapy)

Treating early bladder cancer by putting the drug straight into the bladder through a catheter, so the whole body is spared.

Established
Irreversible electroporation (NanoKnife)

Irreversible electroporation uses short high-voltage pulses that punch permanent holes in tumour cells while sparing nearby vessels and ducts.

Phase 2
Magnetic nanoparticle hyperthermia

Magnetic nanoparticle hyperthermia injects iron-oxide nanoparticles into a tumour and heats them from outside with an alternating magnetic field.

Approved
Percutaneous hepatic perfusion (chemosaturation)

Isolating the liver's circulation with catheters and balloons so that high-dose melphalan can be pumped through it and filtered out before it reaches the rest of the body; approved in 2023 for eye melanoma that has spread to the liver.

Approved
Photoimmunotherapy & photodynamic therapy

An antibody carries a light-sensitive dye to the tumour; shining near-infrared light then bursts the cells.

Phase 2
Photothermal (plasmonic) nanoparticle ablation

Gold nanoshells that accumulate in a tumour and cook it when a near-infrared laser is shone on them.

Phase 2
Sonodynamic therapy

A drug that does nothing until ultrasound hits it, then kills the cells that took it up. Being tested in brain tumours because sound reaches where light cannot.

Approved
Tumour treating fields (TTFields)

Wearable electrodes that deliver alternating electric fields disrupting cancer cell division.

Connected

19top